Atıf Formatları
Pharmacodynamic comparison of a nasal formulation of verapamil and intravenous and oral dosage forms
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

Y. Yazan Et Al. , "Pharmacodynamic comparison of a nasal formulation of verapamil and intravenous and oral dosage forms," DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.22, no.3, pp.281-284, 1996

Yazan, Y. Et Al. 1996. Pharmacodynamic comparison of a nasal formulation of verapamil and intravenous and oral dosage forms. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.22, no.3 , 281-284.

Yazan, Y., Ozer, A., & Erol, K., (1996). Pharmacodynamic comparison of a nasal formulation of verapamil and intravenous and oral dosage forms. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.22, no.3, 281-284.

Yazan, Y, AY Ozer, And K Erol. "Pharmacodynamic comparison of a nasal formulation of verapamil and intravenous and oral dosage forms," DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.22, no.3, 281-284, 1996

Yazan, Y Et Al. "Pharmacodynamic comparison of a nasal formulation of verapamil and intravenous and oral dosage forms." DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.22, no.3, pp.281-284, 1996

Yazan, Y. Ozer, A. And Erol, K. (1996) . "Pharmacodynamic comparison of a nasal formulation of verapamil and intravenous and oral dosage forms." DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.22, no.3, pp.281-284.

@article{article, author={Y Yazan Et Al. }, title={Pharmacodynamic comparison of a nasal formulation of verapamil and intravenous and oral dosage forms}, journal={DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY}, year=1996, pages={281-284} }